Follow
Carola Krause
Carola Krause
codeX-bioMedical Writing services
Verified email at codex-biomed.com - Homepage
Title
Cited by
Cited by
Year
Osteocyte-derived sclerostin inhibits bone formation: its role in bone morphogenetic protein and Wnt signaling
P ten Dijke, C Krause, DJJ De Gorter, CWGM Löwik, RL Van Bezooijen
JBJS 90 (Supplement_1), 31-35, 2008
2612008
Distinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathways
C Krause, O Korchynskyi, K de Rooij, SE Weidauer, DJJ de Gorter, ...
Journal of Biological Chemistry 285 (53), 41614-41626, 2010
1992010
Noggin
C Krause, A Guzman, P Knaus
The international journal of biochemistry & cell biology 43 (4), 478-481, 2011
1862011
Identification of a key residue mediating bone morphogenetic protein (BMP)-6 resistance to noggin inhibition allows for engineered BMPs with superior agonist activity
K Song, C Krause, S Shi, M Patterson, R Suto, L Grgurevic, S Vukicevic, ...
Journal of Biological Chemistry 285 (16), 12169-12180, 2010
1532010
RGK small GTP-binding proteins interact with the nucleotide kinase domain of Ca2+-channel β-subunits via an uncommon effector binding domain
P Béguin, YJA Ng, C Krause, RN Mahalakshmi, MY Ng, W Hunziker
Journal of biological chemistry 282 (15), 11509-11520, 2007
762007
Elevated transforming growth factor β and mitogen-activated protein kinase pathways mediate fibrotic traits of Dupuytren's disease fibroblasts
C Krause, P Kloen, P Ten Dijke
Fibrogenesis & tissue repair 4, 1-15, 2011
752011
Signal transduction cascades controlling osteoblast differentiation
C Krause, DJJ de Gorter, M Karperien, P ten Dijke
Primer on the metabolic bone diseases and disorders of mineral metabolism 7 …, 2008
702008
Signal transduction cascades controlling osteoblast differentiation
C Krause, DJJ de Gorter, M Karperien, P ten Dijke
Primer on the metabolic bone diseases and disorders of mineral metabolism 7 …, 2008
522008
Concurrent inhibition of TGF-β and mitogen driven signaling cascades in Dupuytren’s disease–Non-surgical treatment strategies from a signaling point of view
C Krause, P Kloen
Medical hypotheses 78 (3), 385-388, 2012
132012
Comprehensive analysis of TGF-β and BMP receptor interactomes
MP Belverdi, C Krause, A Guzman, P Knaus
European Journal of Cell Biology 91 (4), 287-293, 2012
122012
Control of bone mass by sclerostin: Inhibiting BMP-and WNT-induced bone formation
DJJ de Gorter, C Krause, P ten Dijke, CWGM Löwik, RL van Bezooijen
Bone Morphogenetic Proteins: From Local to Systemic Therapeutics, 257-276, 2008
72008
The imperative balance of agonist and antagonist for BMP signalling driven adult tissue homeostasis
C Krause
Austin Biomark Diagn 1, 2, 2014
42014
Action-based analysis of discrete regulatory networks with short-term stimuli
C Krause, C Krause, EP de Vink
Proceedings of the 8th International Conference on Computational Methods in …, 2010
32010
Wnt-Signalwege im Knochenstoffwechsel
M Peterlik
Osteologie 20 (03), 197-202, 2011
22011
Lö wik CW, van Bezooijen RL. 2008. Osteocyte-derived sclerostin inhibits bone formation: Its role in bone morphogenetic protein and Wnt signaling
P ten Dijke, C Krause, DJ de Gorter
J Bone Joint Surg Am 90, 31-35, 0
2
Modeling of the BMP mediated co-regulation of the Smad and Non-Smad pathways in the context of cell density
P Gupta, C Krause, P Rikeit, S Röblitz, P Knaus, C Schütte
10th International BMP conference, 2014, Berlin, Germany, 2014
2014
Mathematical modeling of the Smad and Non-Smad BMP signaling pathways in context of cell density
P Gupta, S Röblitz, C Krause, P Knaus, C Schütte
2013
Inhibition of signaling cascades in osteoblast differentiation and fibrosis
C Krause
Int J Biochem Cell Biol 43 (4), 478-81, 2011
2011
Elevated TGF-β and MAP kinase pathways mediate fibrotic traits of Dupuytren’s disease fibroblasts
C Krause, P Kloen, P ten Dijke
The system can't perform the operation now. Try again later.
Articles 1–19